EQBK
Equity Bancshares, Inc.
EQBK has the edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM
JPMorgan Chase & Co.
JPM has slightly lower modeled downside risk, despite its lower overall score.
EQBK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
EQBK's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like EQBK.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
EQBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.4x | $37.06 | -24% |
| Forward | 9.4x | $49.06 | — |
| Fair | 9.9x | $43.90 | -11% |
| Current | 11x | $49.06 | — |
| Expensive | 31x | $138 | +182% |
Historical ranges are pointers, not guarantees.
EQBK has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
EQBK Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for EQBK, but weaker profitability.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
EQBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.22 | +18% |
| Q3 2026 | $4.43 | +263% |
| Q2 2026 | $1.59 | -61% |
| Q1 2026 | $1.18 | -70% |
| Q4 2025 | $1.23 | -69% |
| Q3 2023 | $3.02 | -11% |
| Q2 2023 | $3.15 | -3.1% |
| Q1 2023 | $3.35 | +0.3% |
| Q4 2022 | $3.51 | +2.3% |
EQBK's earnings per share have jumped to their highest in six years: $4.43 over the past year, up from $1.22 the year before. Its recent earnings include one-off gains.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over EQBK on earnings, with more consistent year-over-year improvement.
EQBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $83.7M | +365% |
| Q2 2026 | $81.9M | +40% |
| Q1 2026 | $83.2M | +37% |
| Q4 2025 | $73M | +25% |
| Q3 2025 | $18M | -67% |
| Q2 2025 | $58.4M | +5.3% |
| Q1 2025 | $60.6M | +8.4% |
| Q3 2024 | $55.3M | +11% |
EQBK's revenue has grown year over year for four quarters in a row: $84M last quarter, up 365% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 41% | +248 points |
| Q2 2026 | 41% | +9.7 points |
| Q1 2026 | 27% | -4.4 points |
| Q4 2025 | 36% | +1.3 points |
| Q3 2025 | -207% | -250 points |
| Q2 2025 | 31% | +2.1 points |
| Q1 2025 | 31% | -0.7 points |
| Q4 2024 | 35% | N/A |
EQBK has the edge over JPM on profitability, with a higher operating margin.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
EQBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.9M | +123% |
| Q2 2026 | $35.5M | +37% |
| Q1 2026 | $11.5M | -43% |
| Q4 2025 | -$12.5M | -163% |
| Q3 2025 | $4.5M | -77% |
| Q2 2025 | $26M | +71% |
| Q1 2025 | $20.2M | +90% |
| Q3 2024 | $19.7M | -0.9% |
EQBK has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
EQBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.6x | Healthy |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -2.1x | Net Cash |
| Q4 2025 | -5.1x | Net Cash |
| Q3 2025 | -8.1x | Net Cash |
| Q2 2025 | 1.0x | Very low |
| Q1 2025 | -0.6x | Net Cash |
| Q4 2024 | -0.9x | Net Cash |
EQBK's net debt is about 1.6 years of its operating earnings (EBITDA), after holding more cash than debt a year ago. Net leverage isn't a meaningful measure for financial services companies like EQBK.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over EQBK on leverage, with a lower net debt burden relative to earnings.
EQBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.7 | Neutral |
| Stochastic | 45.4 | Neutral |
EQBK's weekly RSI is 54 (neutral) and its Stochastic is 45 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
EQBK PE vs Financial Services Sector
| Metric | EQBK | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 15% below |
| PE % | 70 | 63 | 7 pts above |
EQBK has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
EQBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $48.2 | 1.8% above |
| 20 week MA | $49.3 | 0.5% below |
| 50 week MA | $47.2 | 4% above |
| 100 week MA | $43.9 | 12% above |
| 200 week MA | $37.8 | 30% above |
EQBK's trend is mixed: it's above four of its five weekly moving averages, and 30% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
EQBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.5 | $21.3 | -30% |
| 2021 | $21.3 | $33.3 | +56% |
| 2022 | $33.3 | $32.9 | -1.3% |
| 2023 | $32.9 | $33.9 | +3.2% |
| 2024 | $33.9 | $42.7 | +26% |
| 2025 | $42.7 | $45.7 | +6.9% |
| 2026 YTD | $45.7 | $49.1 | +7.5% |
EQBK has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.